Genedrive (GDR LN)

Genedrive is a molecular diagnostics company that develops and commercializes a rapid, versatile, and easy-to-use point-of-need molecular diagnostics platform. This platform is used for the diagnosis of infectious diseases, genotyping, and pathogen detection. Their key products include the Genedrive MT-RNR1 ID Kit for preventing antibiotic-induced hearing loss in neonates and the Genedrive CYP2C19 ID Kit for personalized antiplatelet treatment in stroke patients. The company is headquartered in Manchester, United Kingdom, and was founded in 2000.